DEspR Roles in Tumor Vasculo-Angiogenesis, Invasiveness, CSC-Survival and Anoikis Resistance: A ‘Common Receptor Coordinator’ Paradigm

Overview of attention for article published in PLOS ONE, January 2014

Altmetric Badge

Mentioned by

patent: 8 patents

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 30 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 8 patents that reference this research output.

Antibody therapies and methods for treating coronavirus infection

Grant US-11584792-B2

United States of America

Anti-DEspR monoclonal antibody targeted therapy and imaging for cancer and stroke

Grant US-11236169-B2

United States of America

METHODS FOR TREATING NETOSIS AND NEUTROPHIL ACTIVATION

Application EP-3684400-A4

European Patent Office

Polypeptide compositions and methods for site-specific targeting of therapeutic agents

Grant US-10953107-B2

United States of America

Methods for treating netosis and neutrophil activation

Grant US-10849966-B2

United States of America

ANTI-DEspR MONOCLONAL ANTIBODY TARGETED THERAPY AND IMAGING FOR CANCER AND STROKE

Application EP-3341413-A4

European Patent Office

METHODS FOR TREATING NETOSIS AND NEUTROPHIL ACTIVATION

Application WO-2019055958-A1

World Intellectual Property Organisation (WIPO)

Anti-DEspR monoclonal antibody targeted therapy and imaging for cancer and stroke

Grant US-10202457-B2

United States of America